Agenus Inc.

NasdaqCM:AGEN Stock Report

Market Cap: US$112.6m

Agenus Future Growth

Future criteria checks 1/6

Agenus's earnings are forecast to decline at 17.1% per annum while its annual revenue is expected to grow at 11.7% per year. EPS is expected to decline by 10% per annum.

Key information

-17.1%

Earnings growth rate

-10.01%

EPS growth rate

Biotechs earnings growth23.8%
Revenue growth rate11.7%
Future return on equityn/a
Analyst coverage

Low

Last updated24 Dec 2025

Recent future growth updates

Analysts Have Lowered Expectations For Agenus Inc. (NASDAQ:AGEN) After Its Latest Results

May 09
Analysts Have Lowered Expectations For Agenus Inc. (NASDAQ:AGEN) After Its Latest Results

Recent updates

User avatar

BOT/BAL Trials And Cost Reductions Will Shape Future Advances

Strategic cost reduction and asset monetization aim to strengthen financials and fund key projects like BOT/BAL, enhancing potential revenues and earnings.

Agenus: Novel Drugs That Just Are Not Novel

Jul 24

There's No Escaping Agenus Inc.'s (NASDAQ:AGEN) Muted Revenues Despite A 102% Share Price Rise

May 21
There's No Escaping Agenus Inc.'s (NASDAQ:AGEN) Muted Revenues Despite A 102% Share Price Rise

Analysts Have Lowered Expectations For Agenus Inc. (NASDAQ:AGEN) After Its Latest Results

May 09
Analysts Have Lowered Expectations For Agenus Inc. (NASDAQ:AGEN) After Its Latest Results

Benign Growth For Agenus Inc. (NASDAQ:AGEN) Underpins Stock's 25% Plummet

Mar 29
Benign Growth For Agenus Inc. (NASDAQ:AGEN) Underpins Stock's 25% Plummet

Agenus: 2024 May Finally Be The Year For A Major Turnaround

Jan 18

Improved Revenues Required Before Agenus Inc. (NASDAQ:AGEN) Shares Find Their Feet

Dec 22
Improved Revenues Required Before Agenus Inc. (NASDAQ:AGEN) Shares Find Their Feet

News Flash: Analysts Just Made A Huge Upgrade To Their Agenus Inc. (NASDAQ:AGEN) Forecasts

Nov 09
News Flash: Analysts Just Made A Huge Upgrade To Their Agenus Inc. (NASDAQ:AGEN) Forecasts

A Look At The Fair Value Of Agenus Inc. (NASDAQ:AGEN)

Oct 04
A Look At The Fair Value Of Agenus Inc. (NASDAQ:AGEN)

Industry Analysts Just Made A Notable Upgrade To Their Agenus Inc. (NASDAQ:AGEN) Revenue Forecasts

May 10
Industry Analysts Just Made A Notable Upgrade To Their Agenus Inc. (NASDAQ:AGEN) Revenue Forecasts

VBI Vaccines, Agenus to examine VBI-1901 + balstilimab combo for glioblastoma

Oct 12

Agenus New Trials Set It Up For The Long Haul

Sep 27

Agenus: It's Always Tomorrow

Sep 16

Earnings and Revenue Growth Forecasts

NasdaqCM:AGEN - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2027121-89-19N/A3
12/31/2026155-2271N/A3
12/31/20251334-21N/A3
9/30/2025107-35-89-89N/A
6/30/2025102-166-128-128N/A
3/31/2025100-191-146-146N/A
12/31/2024103-227-159-158N/A
9/30/2024160-228-171-170N/A
6/30/2024160-224-186-182N/A
3/31/2024161-240-212-204N/A
12/31/2023156-246-234-224N/A
9/30/2023101-271-255-231N/A
6/30/202399-263-234-198N/A
3/31/202395-240-232-182N/A
12/31/202298-220-228-175N/A
9/30/202290-215-199-151N/A
6/30/202232018-4213N/A
3/31/2022310-19-380N/A
12/31/2021296-24-2410N/A
9/30/20213074-28-3N/A
6/30/202169-226-170-166N/A
3/31/202185-190-150-147N/A
12/31/202088-181-143-139N/A
9/30/202091-174-139-135N/A
6/30/202097-168-135-131N/A
3/31/202085-171-134-130N/A
12/31/2019150-108-23-19N/A
9/30/2019122-126-27-23N/A
6/30/2019115-113N/A-19N/A
3/31/2019115-87N/A-14N/A
12/31/201837-160N/A-131N/A
9/30/201839-147N/A-121N/A
6/30/201829-151N/A-123N/A
3/31/201818-158N/A-120N/A
12/31/201743-121N/A-94N/A
9/30/201740-112N/A-84N/A
6/30/201741-116N/A-82N/A
3/31/201744-113N/A-73N/A
12/31/201623-127N/A-80N/A
9/30/201625-117N/A-83N/A
6/30/201627-89N/A-78N/A
3/31/201627-101N/A-72N/A
12/31/201525-88N/A-47N/A
9/30/201519-98N/A-38N/A
6/30/201514-93N/A-28N/A
3/31/201510-61N/A-25N/A
12/31/20147-43N/A-38N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: AGEN is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: AGEN is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: AGEN is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: AGEN's revenue (11.7% per year) is forecast to grow faster than the US market (10.7% per year).

High Growth Revenue: AGEN's revenue (11.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if AGEN's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/28 14:13
End of Day Share Price 2025/12/26 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Agenus Inc. is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Colleen KusyBaird
Mayank MamtaniB. Riley Securities, Inc.
Michael KingCitizens JMP Securities, LLC